BC, OCN, explained that comprehensive disease and treatment education are essential to adherence for patients with breast ...

Experts discuss treatment options for HER2-positive metastatic breast cancer following progression on trastuzumab deruxtecan (T-DXd), weighing real-world data on tucatinib-capecitabine-trastuzumab ...

Experts discuss how, discuss patient experiences with an oral chemotherapy regimen, highlighting benefits like treatment autonomy, challenges such as pill burden and gastrointestinal toxicities, and ...

Seth Eisenberg, ASN, RN, OCN, BMTCN, explained his research on a toilet cover for oncology nurses to potentially reduce ...

Restaging cancer can be an unfamiliar space, but with more experience, APPs can rely less on MDs for guidance in such cases.

TLX007-CDx was approved by the FDA for PSMA-PET scanning in adult male patients with prostate cancer with suspected ...

Experts discuss the patient case of Janet, a 58-year-old with her 2 positive metastatic breast cancer, and after 14 months on ...

While ambient particle levels differed by HEPA filter status, Splashblocker significantly reduced particles emitted from ...

Patricia Jakel, MN, RN, AOCN, emphasized that the bond oncology nurses have with patients with cancer necessitates honest and ...

Patients with recurrent/metastatic HER2-positive breast cancer experienced durable response and manageable safety from ...

Video content above is prompted by the following: • What are the most common adverse events associated with trastuzumab deruxtecan, and how can they be effectively identified and managed to minimize ...